|
25 July 2001. It has been clear for a number of years that iron accumulates
in areas such as the hippocampus in Alzheimer's disease and
the substantia nigra in Parkinson's disease. Just what this means is
uncertain, especially in given that iron collects in other
areas of the brain as well during normal aging, though in smaller
concentrations. Some clues may come from more obscure neurodegenerative
diseases characterized by iron buildup: two articles in the August issue
of Nature Genetics describe genetic mutations that may cause
neurodegeneration by disrupting iron regulation.
In one study, Susan Hayflick of Oregon Health Sciences University, Bing
Zhou of the University of California in San Francisco, and their colleagues
identify the gene and the mutation responsible for Hallervorden-Spatz
syndrome (HSS), a disease wherein iron accumulates in the basal ganglia.
Although no causal link has been shown between the accumulated iron and the
gradual motor and intellectual deterioration that characterizes HSS,
Hayflick's group offers a candidate for further research. They have
identified a novel gene (dubbed PANK2) that codes for the enzyme
pantothenate kinase, and have determined that defects in PANK2 underlie
HSS. They hypothesize that the link between neuronal damage and excessive
iron in HSS may be that the defective PANK2 protein product fails to tie up
sufficient quantities of cysteine. This amino acid can be turned into an
oxidative radical-already demonstrated to be neurotoxic-by its
interactions with iron. Hayflick and colleagues point out that disturbed
cysteine metabolism has been implicated in both Alzheimer's and Parkinson's
diseases.
Another mechanism whereby iron could harm neurons is suggested by the work
of John Burn and Andrew Curtis of the Institute of Human Genetics in
Newcastle upon Tyne and their colleagues. These researchers have discovered
a new neurodegenerative disorder, which they term "neuroferritinopathy,"
traceable to a mutation in one of the two subunits of ferritin. Ferritin is
an iron-storage molecule, and an obvious possibility is that the mutant
form of the ferritin molecule binds less iron for long-term
storage. In an accompanying News and Views article, Tracey Rouault of the
National Institute of Child Health and Human Development (USA) discusses
how the peculiar polar structure of the neuron (dendrites and axons
bridging distant synapses and cell bodies) might lend itself to damage from
unstable ferritin-iron complexes.-Hakon Heimer.
Reference:(1) Curtis AR, Fey C, Morris CM, Bindoff LA, Ince PG, Chinnery PF, Coulthard A, Jackson MJ, Jackson AP, McHale DP, Hay D, Barker WA, Markham AF, Bates D, Curtis A, Burn J. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001 Aug;28(4):350-4. Abstract
(2) Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001 Aug;28(4):345-9. Abstract
(3) Rouault TA. Iron on the brain. Nat Genet 2001 Aug;28(4):299-300. Abstract
|